| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Entrada Therapeutics, Inc. (TRDA) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 18 sells. TRDA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 2.96M | $21.01M | - | |
| 10% | 2.96M | $21.01M | - | |
| CEO | 526.0K | $3.73M | - | |
| 10% | 381.3K | $2.70M | - | |
| Pres | 216.3K | $1.53M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 6, 2024 | Sethuraman Natarajan83 | President, Research &Develop. | Sell | 18,219 | $18.62 | $339,280.66 | -2.6% | -27.3% | -62.8% | |
| Oct 16, 2024 | Sethuraman Natarajan83 | President, Research &Develop. | Sell | 600 | $18.00 | $10,800.00 | -0.3% | -29.3% | -65.0% | |
| Sep 26, 2024 | Dowden Nathan J70 | President &COO | Sell | 847 | $16.00 | $13,552.00 | -0.7% | +12.5% | -63.2% | |
| Sep 9, 2024 | Wentworth Kory James61 | Chief Financial Officer | Sell | 3,195 | $14.97 | $47,832.35 | -4.0% | +43.2% | -65.8% | |
| Sep 9, 2024 | Dowden Nathan J70 | President &COO | Sell | 2,303 | $15.09 | $34,752.92 | -0.9% | +43.2% | -65.8% | |
| Sep 9, 2024 | Sethuraman Natarajan83 | Chief Scientific Officer | Sell | 3,242 | $15.12 | $49,003.59 | -0.9% | +43.2% | -65.8% | |
| Aug 16, 2024 | Dowden Nathan J70 | President &COO | Sale+OE | 27,097 | $16.27 | $440,801.14 | -9.4% | +15.2% | -68.1% | |
| Jul 15, 2024 | Sethuraman Natarajan83 | Chief Scientific Officer | Sell | 1,238 | $18.00 | $22,284.00 | -0.3% | -0.2% | -64.3% | |
| Jul 15, 2024 | Doshi Dipal62 | CEO | Sell | 1,900 | $17.84 | $33,897.28 | -0.3% | -0.2% | -64.3% | |
| Jul 8, 2024 | Wentworth Kory James61 | Chief Financial Officer | Sell | 1,758 | $14.95 | $26,282.10 | -2.1% | +9.2% | -52.7% |